Joanna Brewer's most recent trade in Adaptimmune Therapeutics Plc - ADR was a trade of 1,612,032 Option to purchase Ordinary Shares done . Disclosure was reported to the exchange on Feb. 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adaptimmune Therapeutics P... | Joanna Brewer | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 1,612,032 | 1,612,032 | - | - | Option to purchase Ordinary Shares | |
| Adaptimmune Therapeutics P... | Joanna Brewer | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 1,074,696 | 1,074,696 | - | - | Option to purchase Ordinary Shares | |
| Adaptimmune Therapeutics P... | Joanna Brewer | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 2,544,432 | 2,544,432 | - | - | Option to purchase Ordinary Shares | |
| Adaptimmune Therapeutics P... | Joanna Brewer | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 565,416 | 565,416 | - | - | Option to purchase Ordinary Shares |